Your body uses the CCNB1 gene to control when cells divide. This gene plays an important role in guiding cells through the last steps before they split into two new cells. If the gene does not work properly, cells may divide at the wrong time or stop dividing normally, which can disrupt growth and tissue repair. Changes in the CCNB1 gene are mainly studied in cancer research because abnormal cell division is a key part of how tumors develop.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Other genes mainly control when certain processes take place, where they occur, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. You can find more detailed information on this topic in the LearnHub.
Overview
CCNB1Gene function
What if the gene works
The CCNB1 gene helps control when cells divide. Its protein helps move cells into mitosis, the stage where one cell splits into two. This supports orderly growth and tissue repair.
Risk
What if the gene does not work
Changes in the CCNB1 gene can range from milder to more severe and may partly or strongly reduce cyclin B1 activity. This can disrupt the step that moves cells into division, so cell growth and timing become less controlled.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the CCNB1 gene is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant. The CCNB1 gene is being studied in cancer research as a biomarker and possible drug target because altered activity can affect cell division.
Gene function
What if the gene works
The CCNB1 gene helps manage one of the busiest moments in cell life: division. Its protein acts as a timed partner for other proteins involved in the cell cycle, helping cells move into and through mitosis, the stage where one cell becomes two. Understanding what the CCNB1 gene does during cell division helps explain how tissues grow and renew in an orderly way.
The CCNB1 gene helps cells keep track of when they are ready for the last steps before division. Its protein builds up at the right point in the cell cycle so division begins on schedule.
CCNB1 works with CDK1, a partner protein that helps turn on mitosis (the stage when one cell splits into two). Together they start the changes a cell needs to divide in an organized way.
During mitosis, this gene's protein helps coordinate events so chromosomes are lined up and shared between the two new cells. That support helps cell division stay controlled and efficient.
Near the end of mitosis, cyclin B1 is cleared away so the cell can finish dividing and return to its usual state. This rise and fall gives the division process a clear beginning and end.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CCNB1 gene can change cyclin B1 so it is unstable, binds its partner less well, or is cleared at the wrong time. This is how variants in the CCNB1 gene affect cell division, with some changes only partly reducing activity and others causing a much larger loss of function. Milder variants may leave some protein activity in place, while more severe variants can markedly disrupt cell cycle control and, in some cells, lead to cell cycle arrest.
How variants are linked to conditions
Current evidence on how variants in the CCNB1 gene are linked to conditions is still developing, and this gene does not yet have a broadly confirmed connection to a specific health condition. If you have a reported CCNB1 variant or a CCNB1-related diagnosis in your record, your doctor or genetic counselor can explain what that result may mean for you.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCNB1 gene. If CCNB1 appears on a test result, its meaning depends a lot on the exact change found and whether the result is from inherited DNA or from a tumor sample.
Inheritance of CCNB1 variants
For people looking into how CCNB1 gene variants are inherited, there is not yet a broadly confirmed disease specific inheritance pattern tied to this gene. As research develops, that picture may become clearer for any health conditions linked to the CCNB1 gene. The CCNB1 gene is located on chromosome 5, which is an autosome, so each person inherits one copy from each parent. That means any CCNB1 gene variant, if present, can be passed through either side of the family.
What does my CCNB1 result mean for my family?
There is not yet a broadly confirmed inherited condition linked to the CCNB1 gene in the way seen for some other genes, so a CCNB1 result usually does not have clear, standard implications for relatives. If you have a specific CCNB1 finding and questions about family risk, a doctor or genetic counselor can explain what it may mean in your situation.
Genetic information
Genetic testing
How you find out about variants
If you need genetic testing for variants in the CCNB1 gene, a lab usually studies DNA from a blood or saliva sample using a multigene panel, exome sequencing, or genome sequencing. It compares the CCNB1 gene sequence with a reference sequence to look for variants and then classifies any change by how likely it is to affect health.
When should I consider getting a genetic test?
There is not yet a broadly established, CCNB1-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, family history, and the guidance of a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, move, or respond to a drug in different ways. These inherited differences are common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CCNB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so concerns about side effects, new symptoms, or whether a treatment is working are best discussed with your doctor. CCNB1 has been studied in cancer research as a possible sign of how some tumors respond to treatment, but it is not used for routine prescribing decisions.
History
In the late 1970s and early 1980s, researchers studying sea urchin and clam embryos discovered cyclins, a group of proteins that rise and fall as cells divide. This work led to recognition of the CCNB1 gene as the human gene for cyclin B1, a key part of the cell cycle research that reshaped modern biology. First described in the scientific literature as part of early genetics, cyclin studies helped show that cell division is guided by timed molecular signals rather than happening at random. Building on this early work, scientists linked cyclin B1 to broader cancer research because unusual activity of this gene was seen in some tumors. Today, the CCNB1 gene is mainly known as part of the landmark story of how researchers uncovered the core controls of cell division.